| Q38850953 | A Review of the Potential of Phytochemicals from Prunus africana (Hook f.) Kalkman Stem Bark for Chemoprevention and Chemotherapy of Prostate Cancer. |
| Q34657338 | A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancer |
| Q40399446 | A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer. |
| Q40488102 | Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer |
| Q36104939 | Angiogenesis and prostate cancer: important laboratory and clinical findings |
| Q42467882 | Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer |
| Q39245540 | Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis. |
| Q55475464 | Association Between 12 Polymorphisms of VEGF/Hypoxia/Angiogenesis Pathway Genes and Risk of Urogenital Carcinomas: A Meta-Analysis Based on Case-Control Studies. |
| Q38371345 | Association between HIF1A rs11549465 polymorphism and risk of prostate cancer: a meta-analysis. |
| Q37426688 | Beta1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1. |
| Q34157307 | Cell-to-cell signaling influences the fate of prostate cancer stem cells and their potential to generate more aggressive tumors |
| Q34975572 | Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy. |
| Q46557783 | Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge |
| Q40308104 | Development of the VCaP androgen-independent model of prostate cancer |
| Q38754205 | Effects of cisplatin on the LSD1-mediated invasion and metastasis of prostate cancer cells |
| Q34769708 | Effects of hormone deprivation and 2-methoxyestradiol combination therapy on hormone-dependent prostate cancer in vivo |
| Q36580598 | Emerging drugs to replace current leaders in first-line therapy for breast cancer |
| Q51549624 | Engineering of human coagulation factor x variants activated by prostate-specific antigen. |
| Q39978152 | Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex). |
| Q38620751 | Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview. |
| Q90190475 | In Vitro Vascular Network Modified to Function as Culture Platform and Angiogenic Induction Potential Test for Cancer Cells |
| Q37182177 | Integrins in prostate cancer progression |
| Q40222498 | Involvement of p38alpha mitogen-activated protein kinase in lung metastasis of tumor cells |
| Q34177229 | Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions |
| Q36417743 | Mechanisms of disease: angiogenesis in urologic malignancies. |
| Q39685717 | Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. |
| Q50677481 | Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis. |
| Q54562952 | No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population. |
| Q35227828 | No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis |
| Q55364912 | PET imaging of 68Ga-NODAGA-RGD, as compared with 18F-fluorodeoxyglucose, in experimental rodent models of engrafted glioblastoma. |
| Q33602963 | Palmitoylated SCP1 is targeted to the plasma membrane and negatively regulates angiogenesis |
| Q34550344 | Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients |
| Q38003667 | Preclinical imaging of the cellular and molecular events in the multistep process of bone metastasis |
| Q28732327 | Primary xenografts of human prostate tissue as a model to study angiogenesis induced by reactive stroma |
| Q34768349 | Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth |
| Q39069308 | Proteomic signatures of angiogenesis in androgen-independent prostate cancer |
| Q36421314 | Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate |
| Q34672464 | SNP-SNP interaction network in angiogenesis genes associated with prostate cancer aggressiveness |
| Q35042977 | Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer |
| Q41120495 | The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy |
| Q35951473 | The evolving biology and treatment of prostate cancer |
| Q33651064 | The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease |
| Q40480219 | Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis. |
| Q39754601 | Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer |
| Q40421578 | Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway |
| Q37111160 | VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide. |
| Q38768131 | c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes |